Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Other Operating Expenses (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Other Operating Expenses for 4 consecutive years, with $289071.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 129.14% to $289071.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.3 million through Dec 2025, up 28.99% year-over-year, with the annual reading at -$3.3 million for FY2025, 28.99% up from the prior year.
  • Other Operating Expenses hit $289071.0 in Q4 2025 for Coya Therapeutics, up from -$665997.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $390000.0 in Q4 2022 to a low of -$1.5 million in Q2 2025.
  • Historically, Other Operating Expenses has averaged -$564592.5 across 4 years, with a median of -$828969.0 in 2024.
  • Biggest five-year swings in Other Operating Expenses: crashed 613.46% in 2024 and later soared 129.14% in 2025.
  • Year by year, Other Operating Expenses stood at $390000.0 in 2022, then tumbled by 50.47% to $193186.0 in 2023, then plummeted by 613.46% to -$991941.0 in 2024, then skyrocketed by 129.14% to $289071.0 in 2025.
  • Business Quant data shows Other Operating Expenses for COYA at $289071.0 in Q4 2025, -$665997.0 in Q3 2025, and -$1.5 million in Q2 2025.